NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
-13.73%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.51B
AUM Growth
+$1.51B
Cap. Flow
+$253M
Cap. Flow %
16.82%
Top 10 Hldgs %
78.74%
Holding
39
New
5
Increased
4
Reduced
1
Closed
2

Top Buys

1
ADAP
Adaptimmune Therapeutics
ADAP
$80.3M
2
SENS icon
Senseonics Holdings
SENS
$75.2M
3
TSRO
TESARO, Inc.
TSRO
$62.6M
4
KA
Kineta, Inc. Common Stock
KA
$29.8M
5
ELGX
Endologix Inc
ELGX
$20.8M

Top Sells

1
TRIV
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$26.2M
2
NVRO
NEVRO CORP.
NVRO
$18.7M
3
AKTX
Akari Therapeutics
AKTX
$1.77M

Sector Composition

1 Healthcare 69.03%
2 Communication Services 11.7%
3 Technology 11.12%
4 Consumer Discretionary 1.33%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
CSBR icon
26
Champions Oncology
CSBR
$93.8M
$5.69M 0.38% 1,562,500 – –
ORKA
27
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
$5.07M 0.34% 1,460,209 – –
ZSAN
28
DELISTED
Zosano Pharma Corporation
ZSAN
$4.97M 0.33% 2,158,543 – –
VIRX
29
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.21M 0.28% 7,789,644 – –
ARQL
30
DELISTED
Arqule Inc
ARQL
$4.03M 0.27% 2,520,316 – –
ROKA
31
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$2.22M 0.15% 3,220,433 – –
AVTX icon
32
Avalo Therapeutics
AVTX
$122M
$2.22M 0.15% 595,435 – –
OREX
33
DELISTED
Orexigen Therapeutics, Inc.
OREX
$2.08M 0.14% 3,709,000 – –
PRTK
34
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$1.9M 0.13% 125,004 – –
GYRE icon
35
Gyre Therapeutics
GYRE
$703M
$1.1M 0.07% 652,380 – –
AGRX
36
DELISTED
Agile Therapeutics, Inc
AGRX
$829K 0.06% 133,488 – –
AKTX
37
Akari Therapeutics
AKTX
$24.8M
– – -121,970 Closed -$1.77M
TRIV
38
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
– – -3,945,191 Closed -$26.2M
1
2